BioSpace News Archive

Kineta, Inc., a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced that Shawn Iadonato, Ph.D., Chief Executive Officer at Kineta, will present at the Jefferies Healthcare Conference, being held in New York, NY from June 7-9, 2023.

Tonix Pharmaceuticals today announced the isolation and functional characterization of the two mirror image isomers of racemic tianeptine, which is marketed outside the U.S. as a treatment for major depressive disorder (MDD).

Zentalis ® Pharmaceuticals, Inc. today announced that the Company will host an investor update call to share the safety and efficacy results from its ongoing monotherapy dose optimization Phase 1 study of azenosertib, its potentially first-in-class WEE1 inhibitor product candidate.

Global biopharmaceutical services provider Allucent announced today that it has partnered with THREAD, an innovative DCT and eCOA technology provider, to launch Allucent Patient Direct Trials.

Cepheid, a leading molecular diagnostics company, announced today that Vitor Rocha has officially joined the company in the role of President.

908 Devices Inc. today announced it will participate in the upcoming William Blair 43rd Annual Growth Stock Conference.

Verge Genomics announced that Emerald Innovations’ wireless digital health technology will be used to capture critical patient data in its planned Phase 1b proof-of-concept study of the PIKfyve inhibitor VRG50635, a novel therapeutic in clinical development for amyotrophic lateral sclerosis (ALS).

iSpecimen Inc. today announced that Tracy Curley, CEO of iSpecimen, will participate in the Healthcare IT Virtual Conference hosted by Maxim Group LLC (“Maxim”) and M-Vest, a division of Maxim, on Thursday, June 1, 2023.

Quipt Home Medical Corp., a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is very pleased to announce it is on a preliminary list dated May 19, 2023 issued by FTSE Russell to join the Russell 2000® and 3000® Indexes at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the U.S. market opens on June 26, 2023.

Kura Oncology, Inc. today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in the following events at upcoming investor conferences.